Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127187132 | 12718713 | 2 | F | 20160829 | 20160906 | 20160906 | 20160908 | PER | US-GLAXOSMITHKLINE-US2016127334 | GLAXOSMITHKLINE | 61.44 | YR | F | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127187132 | 12718713 | 1 | PS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | N | WA6W | 21433 | 1 | DF | BID | |||||
| 127187132 | 12718713 | 2 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 127187132 | 12718713 | 3 | C | AZELASTINE | AZELASTINE | 1 | 0 | ||||||||||||
| 127187132 | 12718713 | 4 | C | CLOBETASOL CREAM | CLOBETASOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127187132 | 12718713 | 1 | Sarcoidosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127187132 | 12718713 | Aphonia | |
| 127187132 | 12718713 | Drug ineffective | |
| 127187132 | 12718713 | Ear discomfort | |
| 127187132 | 12718713 | Retching |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127187132 | 12718713 | 1 | 20160829 | 20160831 | 0 |